The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Duration of Prophylaxis Against Venous Thromboembolism With Fondaparinux After Hip Fracture Surgery<subtitle>A Multicenter, Randomized, Placebo-Controlled, Double-blind Study</subtitle>
Abstract
BACKGROUND: The benefit of thromboprophylaxis for 1 month has never been evaluated in patients undergoing hip fracture surgery, a setting in the highest risk category for postoperative venous thromboembolism (VTE). METHODS: In a double-blind multicenter trial, 656 patients undergoing hip fracture surgery were randomly assigned to receive prophylaxis with a once-daily subcutaneous injection of either 2.5 mg of fondaparinux sodium or placebo for 19 to 23 days. Before randomization, all patients had received fondaparinux for 6 to 8 days. The primary efficacy outcome was VTE occurring during the double-blind period (deep vein thrombosis detected by mandatory bilateral venography or documented symptomatic deep vein thrombosis or pulmonary embolism). The main safety outcome was major bleeding. RESULTS: The primary efficacy outcome was assessed in 428 patients. Fondaparinux reduced the incidence of VTE compared with placebo from 35.0% (77/220) to 1.4% (3/208), with a relative reduction in risk of 95.9% (95% confidence interval, 87.2%-99.7%; P<.001). Similarly, the incidence of symptomatic VTE was significantly lower with fondaparinux (1/326; 0.3%) than with placebo (9/330; 2.7%). The relative reduction in risk was 88.8% (P =.02). Although there was a trend toward more major bleeding in the fondaparinux group than in the placebo group (P =.06), there were no differences between the 2 groups in the incidence of clinically relevant bleeding (leading to death, reoperation, or critical organ bleeding). CONCLUSIONS: Extended prophylaxis with fondaparinux for 3 weeks after hip fracture surgery reduced the risk of VTE by 96% and was well tolerated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · The Lancet · doi:10.1016/s0140-6736(00)02110-3 · Cited by 1,076
Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for Cancer
Bergqvist, D., Agnelli, G., Cohen, A. T., Eldor, A., Nilsson, P. E., Le Moigne-Amrani, A., & Dietrich-Neto, F. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012385 · Cited by 1,052
Roentgen Diagnosis of Venous Thrombosis in the Leg
Rabinov, K. (1972) · Archives of Surgery · doi:10.1001/archsurg.1972.04180020014004 · Cited by 740
Turpie, A. G. G. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.16.1833 · Cited by 736
Eriksson, B. I., Bauer, K. A., Lassen, M. R., & Turpie, A. G. G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011100 · Cited by 631
Self-citationEikelboom, J. W., Quinlan, D. J., & Douketis, J. D. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05249-1 · Cited by 513
Bergqvist, D., Benoni, G., Björgell, O., Fredin, H., Hedlundh, U., Nicolas, S., Nilsson, P., & Nylander, G. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609053351002 · Cited by 457
Planes, A., Vochelle, N., Darmon, J.-Y., Fagola, M., Bellaud, M., & Huet, Y. (1996) · The Lancet · doi:10.1016/s0140-6736(96)01453-5 · Cited by 432
A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis after Total Hip Replacement
Turpie, A. G. G., Gallus, A. S., & Hoek, J. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103013440901 · Cited by 380
Differences in mortality after fracture of hip: the East Anglian audit
Todd, C. J., Freeman, C. J., Camilleri-Ferrante, C., Palmer, C. R., Hyder, A., Laxton, C. E., Parker, M. J., Payne, B. V., & Rushton, N. (1995) · BMJ · doi:10.1136/bmj.310.6984.904 · Cited by 323
Hull, R. D., Pineo, G. F., Stein, P. D., Mah, A. F., MacIsaac, S. M., Dahl, O. E., Butcher, M., Brant, R. F., Ghali, W. A., Bergqvist, D., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-10-200111200-00006 · Cited by 299
Dahl, O. E., Andreassen, G. S., Aspelin, T., et al. (1997) · PubMed · Cited by 264
Nicolaides, A. N., Breddin, H. K., Fareed, J., Goldhaber, S. Z., Haas, S., Hull, R., Kalodiki, E., Myers, K. V., Samama, M. M., & Sasahara, A. (2001) · PubMed · Cited by 263
Prolonged Enoxaparin Therapy to Prevent Venous Thromboembolism After Primary Hip or Knee Replacement
Comp, P. C., Spiro, T. E., Friedman, R. J., Whitsett, T. L., Johnson, G. J., Gardiner, G. A., Landon, G. C., & Jové, M. (2001) · The Journal of Bone and Joint Surgery-American Volume · doi:10.2106/00004623-200103000-00004 · Cited by 221
Hull, R. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2208 · Cited by 210
Lassen, M. R., Borris, L. C., Anderson, B., Jensen, H. P., Bro, H. P. S., Andersen, G., Petersen, A. O., Siem, P., Hørlyck, E., Jensen, B., et al. (1998) · Thrombosis Research · doi:10.1016/s0049-3848(98)00018-8 · Cited by 177
Cited by
Prevention of Venous Thromboembolism
Geerts, W. H., Pineo, G. F., Heit, J. A., Bergqvist, D., Lassen, M. R., Colwell, C. W., & Ray, J. G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.338s · Cited by 5,895
Prevention of Venous Thromboembolism
Geerts, W. H., Bergqvist, D., Pineo, G. F., Heit, J. A., Samama, C. M., Lassen, M. R., & Colwell, C. W. (2008) · Chest · doi:10.1378/chest.08-0656 · Cited by 3,829
Kahn (2012) · doi:10.1378/chest.11-2296 · Cited by 2,693
Prevention of VTE in Orthopedic Surgery Patients
Falck-Ytter, Y., Francis, C. W., Johanson, N. A., Curley, C., Dahl, O. E., Schulman, S., Ortel, T. L., Pauker, S. G., & Colwell, C. W. (2012) · Chest · doi:10.1378/chest.11-2404 · Cited by 1,930
Eriksson, B. I., Dahl, O. E., Rosencher, N., Kurth, A. A., van Dijk, C. N., Frostick, S. P., Prins, M. H., Hettiarachchi, R., Hantel, S., Schnee, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61445-7 · Cited by 1,116
Self-citation
Metadata
- Authors
- Eriksson, B. I.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2003-06-09
- Volume
- 163
- Issue
- 11
- Pages
- 1337
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2088494721
- Cited by
- 345
- References
- 17
- FWCI
- 21.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.